Venus Medtech Hangzhou Inc (2500) - Product Pipeline Analysis, 2023 Update

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $750	57 Pages	GlobalData	July, 2023	GBDT18100619

Best Price Guarantee
Price	from $750
Length	57 Pages
Publisher	GlobalData
Published Date	July, 2023
SKU	GBDT18100619

Europe Bearings Market Summary, Competitive Analysis and Forecast to 2027

Summary

Bearings in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

Bearings are mechanical elements that reduce friction between moving elements and limit relative motion to desired motion. There are three main types of bearings: ball bearings, roller bearings, and other bearings. Other bearing segment’s scope includes slewing bearings, thrust ball bearings, sleeve bearings, and specialty bearings.
The European bearings market had total revenues of $21.3 billion in 2022, representing a compound annual growth rate (CAGR) of 1.1% between 2017 and 2022.
The automotive segment accounted for market's the largest proportion in 2022, with total revenues of $7.2 billion, equivalent to 33.8% of the market's overall value.
Large-scale investment and industrial expansion have resulted in moderate growth of the European bearings market in 2022. According to Eurostat, in 2022, the annual average industrial production in the EU and eurozone climbed by 1.9% and by 0.9%, respectively.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the bearings market in Europe
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the bearings market in Europe
Leading company profiles reveal details of key bearings market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Europe bearings market with five year forecasts

Reasons to Buy

What was the size of the Europe bearings market by value in 2022?
What will be the size of the Europe bearings market in 2027?
What factors are affecting the strength of competition in the Europe bearings market?
How has the market performed over the last five years?
Who are the top competitors in Europe's bearings market?

Venus Medtech Hangzhou Inc Company Overview: Venus Medtech Hangzhou Inc Company Snapshot; Venus Medtech Hangzhou Inc Pipeline Products and Ongoing Clinical Trials Overview; Venus Medtech Hangzhou Inc – Pipeline Analysis Overview; Venus Medtech Hangzhou Inc - Key Facts; Venus Medtech Hangzhou Inc - Major Products and Services; Venus Medtech Hangzhou Inc Pipeline Products by Development Stage; Venus Medtech Hangzhou Inc Ongoing Clinical Trials by Trial Status; Venus Medtech Hangzhou Inc Pipeline Products Overview; AR Valve; AR Valve Product Overview; Cardiovalve Transcatheter Tricuspid Valve System; Cardiovalve Transcatheter Tricuspid Valve System Product Overview; Cardiovalve Transcatheter Tricuspid Valve System Clinical Trial; Cardiovalve Transfemoral Mitral Valve System; Cardiovalve Transfemoral Mitral Valve System Product Overview; Cardiovalve Transfemoral Mitral Valve System Clinical Trial; Echomplish Device; Echomplish Device Product Overview; Lim Transseptal System; Lim Transseptal System Product Overview; Limbus; Limbus Product Overview; Liwen RF Ablation System; Liwen RF Ablation System Product Overview; Liwen RF Ablation System Clinical Trial; Small Incision Surgical Valve; Small Incision Surgical Valve Product Overview; Transapical Trinity Aortic Valve Implantation System; Transapical Trinity Aortic Valve Implantation System Product Overview; Transcatheter Tricuspid Valve Replacement Device; Transcatheter Tricuspid Valve Replacement Device Product Overview; Transfemoral Trinity Aortic Valve Implantation System; Transfemoral Trinity Aortic Valve Implantation System Product Overview; Tresillo System; Tresillo System Product Overview; TriGUARD3 Cerebral Embolic Protection Device; TriGUARD3 Cerebral Embolic Protection Device Product Overview; Tumbao EndoVascular Aortic Repair System; Tumbao EndoVascular Aortic Repair System Product Overview; Venus PowerX Valve; Venus PowerX Valve Product Overview; Venus Vitae Valve; Venus Vitae Valve Product Overview; Venus Vitae Valve Clinical Trial; Venus-Neo; Venus-Neo Product Overview; Venus-Neo Clinical Trial; VenusA-Plus; VenusA-Plus Product Overview; VenusA-Valve; VenusA-Valve Product Overview; VenusA-Valve Clinical Trial; VenusP-Valve; VenusP-Valve Product Overview; VenusP-Valve Clinical Trial; Venus Medtech Hangzhou Inc - Key Competitors; Venus Medtech Hangzhou Inc - Key Employees; Venus Medtech Hangzhou Inc - Locations And Subsidiaries; Head Office; Other Locations & Subsidiaries; Joint Venture; Recent Developments; Venus Medtech Hangzhou Inc, Recent Developments; Jun 08, 2023: Venus Medtech Hangzhou Notice of 2022 Annual General Meeting; Jun 02, 2023: Venus Medtech Hangzhou proposes a change of auditors, adoption of the share option scheme and resignation of joint company secretary and chief financial officer; Mar 18, 2022: Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercialization of TPVR system; Sep 29, 2021: Venus Medtech Hangzhou Announces 2021 Interim Report; Aug 31, 2021: Venus Medtech Announces Interim Results for the Six Months Ended June 30, 2021; Mar 25, 2021: Keystone Heart and InterValve Medical enter distribution agreement for balloon aortic valvuloplasty portfolio; May 04, 2020: Venus Medtech and Opus Medical partner for TMVR and TTVR in China; May 02, 2020: Venus Medtech and Opus Medical Therapies announce partnership for transcatheter mitral valve replacement (TMVR) and transcatheter tricuspid valve replacement (TTVR) in greater China market; Mar 11, 2020: Keystone Heart secures CE Mark for cerebral embolic protection device; Feb 21, 2020: Cardiovalve’s Transcatheter Tricuspid Valve System gets FDA approval; Appendix; Methodology; About GlobalData; Contact Us; Disclaimer
List of Tables: Table 1: Venus Medtech Hangzhou Inc Pipeline Products and Ongoing Clinical Trials Overview; Table 2: Venus Medtech Hangzhou Inc Pipeline Products by Equipment Type; Table 3: Venus Medtech Hangzhou Inc Pipeline Products by Indication; Table 4: Venus Medtech Hangzhou Inc, Key Facts; Table 5: Venus Medtech Hangzhou Inc, Major Products and Services; Table 6: Venus Medtech Hangzhou Inc Number of Pipeline Products by Development Stage; Table 7: Venus Medtech Hangzhou Inc Pipeline Products Summary by Development Stage; Table 8: Venus Medtech Hangzhou Inc Ongoing Clinical Trials by Trial Status; Table 9: Venus Medtech Hangzhou Inc Ongoing Clinical Trials Summary; Table 10: AR Valve - Product Status; Table 11: AR Valve - Product Description; Table 12: Cardiovalve Transcatheter Tricuspid Valve System - Product Status; Table 13: Cardiovalve Transcatheter Tricuspid Valve System - Product Description; Table 14: Cardiovalve Transcatheter Tricuspid Valve System - Safety and Performance of the Cardiovalve TR Replacement System for Tricuspid Regurgitation; Table 15: Cardiovalve Transfemoral Mitral Valve System - Product Status; Table 16: Cardiovalve Transfemoral Mitral Valve System - Product Description; Table 17: Cardiovalve Transfemoral Mitral Valve System - Cardiovalve Transfemoral Mitral Valve System in Patients at High Surgical Risk with Severe Mitral Regurgitation; Table 18: Cardiovalve Transfemoral Mitral Valve System - Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation; Table 19: Cardiovalve Transfemoral Mitral Valve System - Early Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System; Table 20: Cardiovalve Transfemoral Mitral Valve System - European Feasibility Study of High Surgical Risk Patients with Severe Mitral Regurgitation Treated with the Cardiovalve Transfemoral Mitral Valve System: AHEAD Study; Table 21: Cardiovalve Transfemoral Mitral Valve System - Evaluation of a Transcatheter Mitral Valve Replacement System for the Treatment of Severe Mitral Regurgitation with High Surgical Risk: A Chinese Feasibility Study; Table 22: Echomplish Device - Product Status; Table 23: Echomplish Device - Product Description; Table 24: Lim Transseptal System - Product Status; Table 25: Lim Transseptal System - Product Description; Table 26: Limbus - Product Status; Table 27: Limbus - Product Description; Table 28: Liwen RF Ablation System - Product Status; Table 29: Liwen RF Ablation System - Product Description; Table 30: Liwen RF Ablation System - Confirmatory Clinical Study of Liwen RF Ablation System; Table 31: Small Incision Surgical Valve - Product Status; Table 32: Small Incision Surgical Valve - Product Description; Table 33: Transapical Trinity Aortic Valve Implantation System - Product Status; Table 34: Transapical Trinity Aortic Valve Implantation System - Product Description; Table 35: Transcatheter Tricuspid Valve Replacement Device - Product Status; Table 36: Transcatheter Tricuspid Valve Replacement Device - Product Description; Table 37: Transfemoral Trinity Aortic Valve Implantation System - Product Status; Table 38: Transfemoral Trinity Aortic Valve Implantation System - Product Description; Table 39: Tresillo System - Product Status; Table 40: Tresillo System - Product Description; Table 41: TriGUARD3 Cerebral Embolic Protection Device - Product Status; Table 42: TriGUARD3 Cerebral Embolic Protection Device - Product Description; Table 43: Tumbao EndoVascular Aortic Repair System - Product Status; Table 44: Tumbao EndoVascular Aortic Repair System - Product Description; Table 45: Venus PowerX Valve - Product Status; Table 46: Venus PowerX Valve - Product Description; Table 47: Venus Vitae Valve - Product Status; Table 48: Venus Vitae Valve - Product Description; : isease; Table 50: Venus-Neo - Product Status; Table 51: Venus-Neo - Product Description; Table 52: Venus-Neo - A Prospective Multicenter Pivotal Study to Evaluate Safety and Effectiveness of Venus-Neo Surgical Aortic Valve; Table 53: VenusA-Plus - Product Status; Table 54: VenusA-Plus - Product Description; Table 55: VenusA-Valve - Product Status; Table 56: VenusA-Valve - Product Description; Table 57: VenusA-Valve - Venus Panorama II Post-marketing Registry Study; Table 58: VenusP-Valve - Product Status; Table 59: VenusP-Valve - Product Description; Table 60: VenusP-Valve - Implantation of the Venus P-Valve in the Pulmonic Position in Patients with Native Outflow Tracts; Table 61: VenusP-Valve - Real-World Evidence - An Observational Study of Venus P-ValveTM System in the Treatment of Patients With Native RVOT Dysfunction; Table 62: VenusP-Valve - Study on Self-expanding Transcatheter Pulmonic Valve Replacement with VenusP-Valve in for the Treatment of Severe Pulmonary Regurgitation in Patients after Congenital Heart Defects (CHD) Procedure with Native Right Ventricular Outflow Tract (RVOT); Table 63: VenusP-Valve - Study on the Treatment of Severe Pulmonary Regurgitation in Patients by Self-expanding Transcatheter Pulmonic Valve Replacement with VenusP-Valve; Table 64: Venus Medtech Hangzhou Inc, Key Employees; Table 65: Venus Medtech Hangzhou Inc, Subsidiaries; Table 66: Venus Medtech Hangzhou Inc, Joint Venture; Table 67: Glossary
List of Figures: Figure 1: Venus Medtech Hangzhou Inc Pipeline Products by Equipment Type; Figure 2: Venus Medtech Hangzhou Inc Pipeline Products by Development Stage; Figure 3: Venus Medtech Hangzhou Inc Ongoing Clinical Trials by Trial Status